OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
Kumar Ganesan, Cong Xu, Jianming Wu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 9, pp. 1849-1866
Closed Access | Times Cited: 43
Kumar Ganesan, Cong Xu, Jianming Wu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 9, pp. 1849-1866
Closed Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
An update on promising and emerging protein kinase B/AKT inhibitors for breast cancer
Riccardo Asnaghi, Gabriele Antonarelli, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy (2025)
Open Access | Times Cited: 1
Riccardo Asnaghi, Gabriele Antonarelli, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy (2025)
Open Access | Times Cited: 1
Fibroblast Growth Factor Receptor 4 Promotes Triple‐Negative Breast Cancer Progression via Regulating Fatty Acid Metabolism Through the AKT/RYR2 Signaling
Jinhui Ye, Song Wu, Qiang Quan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 23
Open Access | Times Cited: 4
Jinhui Ye, Song Wu, Qiang Quan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 23
Open Access | Times Cited: 4
A new peptide inhibitor of C1QBP exhibits potent anti‐tumour activity against triple negative breast cancer by impairing mitochondrial function and suppressing homologous recombination repair
Xingxing Li, Yue Wu, Min Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Xingxing Li, Yue Wu, Min Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
FASN inhibition shows the potential for enhancing radiotherapy outcomes by targeting glycolysis, AKT, and ERK pathways in breast cancer
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Ching-I Chen, Deng-Yu Kuo, Hui-Yen Chuang
International Journal of Radiation Biology (2025), pp. 1-12
Open Access
Pseudostellaria heterophylla (Miq.) Pax, a Traditional Folk Medicine, Ameliorates Colorectal Cancer by Remodeling the Tumor Immune Microenvironment
Gui Yang, Hui Wu, Heng Fan
Journal of Ethnopharmacology (2025) Vol. 342, pp. 119362-119362
Closed Access
Gui Yang, Hui Wu, Heng Fan
Journal of Ethnopharmacology (2025) Vol. 342, pp. 119362-119362
Closed Access
Anticancer Effects of MAPK6 siRNA ‐Loaded PLGA Nanoparticles in the Treatment of Breast Cancer
Ceyhun Toruntay, Fatma Şayan Poyraz, Seda Süsgün, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Ceyhun Toruntay, Fatma Şayan Poyraz, Seda Süsgün, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
Didymin Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cells by Modulating the PI3K/Akt Pathway
Tong Zhang, Bin Xu
Nutrition and Cancer (2025), pp. 1-16
Closed Access
Tong Zhang, Bin Xu
Nutrition and Cancer (2025), pp. 1-16
Closed Access
Novel Strategy of Antibody Affinity Maturation and Enhancement of Nucleolin‐Mediated Antibody‐Dependent Cellular Cytotoxicity Against Triple‐Negative Breast Cancer
Rita Ribeiro, Jorge M. B. Vítor, Anastasiya Voronovska, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 1
Closed Access
Rita Ribeiro, Jorge M. B. Vítor, Anastasiya Voronovska, et al.
Biotechnology Journal (2025) Vol. 20, Iss. 1
Closed Access
Smurf2 Suppresses Proliferation and Cell Cycle of Triple‐Negative Breast Cancer Cells by Promoting the Polyubiquitination and Degradation of RPL35A
Siyu Wei, Yuying Liu, Zhihao Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Siyu Wei, Yuying Liu, Zhihao Wang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Sotorasib resistance triggers epithelial-mesenchymal transition and activates AKT and P38-mediated signaling
Raquel Megid, Guilherme Ribeiro, Izabela Natália Faria Gomes, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Raquel Megid, Guilherme Ribeiro, Izabela Natália Faria Gomes, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
TAF7 Directly Targets SAA1 to Enhance Triple-Negative Breast Cancer Metastasis via Phosphorylating E-Cadherin and N-Cadherin
Wanjun Zhang, Jun Wang, Hanning Li, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111989-111989
Open Access
Wanjun Zhang, Jun Wang, Hanning Li, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 111989-111989
Open Access
Sennoside B inhibits malignant phenotypes of triple-negative breast cancer cells and represses ERK/AKT/STAT5 signaling
Lijun Li, Shanshan Xie
Pathology - Research and Practice (2025), pp. 155842-155842
Closed Access
Lijun Li, Shanshan Xie
Pathology - Research and Practice (2025), pp. 155842-155842
Closed Access
The Purinergic Ligand‐Gated Ion Channel 7 Receptor Promotes the Proliferation, Invasion, and Migration of Breast Cancer Cells
Xin Wang, Xiaoxiang Peng, Yahui Cao, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Xin Wang, Xiaoxiang Peng, Yahui Cao, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors
Onur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Onur Baş, Mert Tokatlı, Mehmet Şavklıyıldız, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
Increasing RB1 Expression by Targeting EZH2 in Triple‐Negative Breast Cancer
Rui Yang, Liyan Fei, Yingfei Xue, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Rui Yang, Liyan Fei, Yingfei Xue, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Diagnosis, Prognosis, and Treatment of Triple-Negative Breast Cancer: A Review
Huan Jie, Wenhui Ma, Cong Huang
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 265-274
Open Access
Huan Jie, Wenhui Ma, Cong Huang
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 265-274
Open Access
Yiqi Qingre Gao alleviates renal fibrosis in UUO mice via PI3K/AKT pathway
Qi Jin, Qian Li, Liping Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Qi Jin, Qian Li, Liping Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Calpain 2 Isoform‐Specific Cleavage of Filamin A Enhances HIF1α Nuclear Translocation, Promoting Metastasis in Triple‐Negative Breast Cancer
Kyung‐Hwa Jeon, Seojeong Park, Eun Seon Pak, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Kyung‐Hwa Jeon, Seojeong Park, Eun Seon Pak, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
PSMC2 upregulation enhances epithelial-to-mesenchymal transition in glioblastoma via activating AKT/GSK3β/β-catenin axis
Pritam Roy, K Deepak, Prithwish Kola, et al.
Cellular Signalling (2025), pp. 111809-111809
Closed Access
Pritam Roy, K Deepak, Prithwish Kola, et al.
Cellular Signalling (2025), pp. 111809-111809
Closed Access
Total flavonoids of litchi seed inhibit breast cancer metastasis by regulating the PI3K/AKT/mTOR and MAPKs signaling pathways
Xin Yang, Shoushi Liu, Ying Liu, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 229-249
Open Access
Xin Yang, Shoushi Liu, Ying Liu, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 229-249
Open Access
Nanoconjugate Carrying pH-Responsive Transferrin Receptor-Targeted Hesperetin Triggers Triple-Negative Breast Cancer Cell Death through Oxidative Attack and Assemblage of Pro-Apoptotic Proteins
Dibyendu Giri, Surya Kanta Dey, Sounik Manna, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 11, pp. 7556-7573
Closed Access | Times Cited: 3
Dibyendu Giri, Surya Kanta Dey, Sounik Manna, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 11, pp. 7556-7573
Closed Access | Times Cited: 3
Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer
Yujie Sun, Qiang Zhang, Shijie Cao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Yujie Sun, Qiang Zhang, Shijie Cao, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4/AKT/mTOR signaling pathway
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
